Malignant Head and Neck Neoplasm — Trials

Malignant Head and Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,449 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,432
Recruiting: 781
Ph III recruiting: 109
Growth YoY: +20.5%
Industry share: 18%
Top sponsor: Sun Yat-sen University
Termination share: 29.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (629)

clinicaltrialsPublishedShowing 651–700 of 5,449 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07679997	Trilaciclib Combined With Immunochemotherapy for R/M HNSCC	not yet recruiting	Phase 2	32	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER	0	Jul 1, 2026	clinicaltrials
NCT02057510	Observational Study of Dental Outcomes in Head and Neck Cancer Patients(ORARAD)	completed	—	613	Wake Forest University Health SciencesOTHER	1	Jun 30, 2026